Scientists Rewire Immune Cells To Supercharge Cancer-Fighting Power

Scientists Rewire Immune Cells To Supercharge Cancer-Fighting Power

In This Article

Article Contents

White Blood Cells Attacking Cancer Cell Close
A new study shows that blocking one protein can reprogram immune cells to fight cancer more powerfully, offering hope for next-generation therapies. Credit: Shutterstock

Blocking a single protein boosts T cell metabolism and tumor-fighting strength. The discovery could lead to next-generation cancer immunotherapies.

Scientists have identified a strategy to greatly enhance the cancer-fighting abilities of the immune system’s T cells. By inhibiting a protein known as Ant2, they succeeded in reshaping how these cells produce and use energy, effectively redesigning their internal power systems.

This adjustment makes T cells stronger, more durable, and more efficient at targeting tumors. The discovery opens new possibilities for therapies that reinforce the body’s natural defenses, offering a more precise and effective form of cancer treatment.

International team leads breakthrough

A recent study suggests the potential for a new wave of cancer therapies that rely on training the immune system to perform more effectively. The work, led by PhD student Omri Yosef and Prof. Michael Berger at the Hebrew University Faculty of Medicine, brought together collaborators including Prof. Magdalena Huber of Philipps University of Marburg and Prof. Eyal Gottlieb of the University of Texas MD Anderson Cancer Center. Their findings show that carefully adjusting immune cell metabolism significantly boosts the cells’ ability to destroy tumors.

Central to the research is a striking observation: when T cells—the immune system’s front-line fighters—are compelled to change the way they generate and manage energy, they become far more adept at recognizing and eliminating cancer cells.

Tumor Size Under Different Treatment Conditions
This image displays tumors collected at the end of the experiment from three experimental groups: untreated controls, OT-I CD8+ T cell recipients without additional treatment, and those receiving OT-I CD8+ T cells followed by ATR therapy. The 5 mm scale bar highlights visible differences in tumor volume. Growth was measured daily starting on day 17 post-implantation to evaluate treatment effectiveness. Credit: Omri Yosef and the authors

“By disabling Ant2, we triggered a complete shift in how T cells produce and use energy,” explains Prof. Berger. “This reprogramming made them significantly better at recognizing and killing cancer cells.” In simpler terms, blocking this protein forces the immune cells to adapt their metabolism, turning them into stronger, faster, and more aggressive cancer fighters.

Mitochondria as cellular engines

Published in DOI: 10.1038/s41467-025-59310-3

Never miss a breakthrough: Join the SciTechDaily newsletter.

Full article can be found at: https://scitechdaily.com/scientists-rewire-immune-cells-to-supercharge-cancer-fighting-power/

Key Terms

SciTechDaily offers the best intelligent, informed science and technology coverage and analysis you can find on a daily basis, sourcing a huge range of great writers and excellent research institutes. It was founded in 1998 by Vicki Hyde, a friend of Denis Dutton (of Arts & Letters Daily fame) and was essentially a sister site to ALDaily.com. The idea was to link to the most thought-provoking, well researched online items in the world of science and technology. (Originally, this site was known as SciTech Daily Review, but it was simplified to SciTechDaily in 2011. The address has always remained SciTechDaily.com.)